The prevention and treatment of coronary heart disease is a major challenge in the overall management of the patient with type 2 diabetes. Diabetic dyslipidaemia is an important risk factor and is open to therapeutic intervention. However, as yet there are no primary or secondary coronary heart disease prevention trials of lipid-lowering therapy reported in diabetic populations. In this review, on-going clinical trials of lipid-lowering therapy in specific diabetic populations will be described.
|Number of pages||6|
|Journal||Current Opinion in Lipidology|
|Publication status||Published - Dec 2000|
Betteridge, D. J., Colhoun, H., & Armitage, J. (2000). Status report of lipid-lowering trials in diabetes. Current Opinion in Lipidology, 11(6), 621-626. http://journals.lww.com/co-lipidology/pages/default.aspx